Onconetix, Inc.
ONCO
$0.95
-$0.06-6.25%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 815.40K | 1.22M | 1.33M | 1.93M | 2.52M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 815.40K | 1.22M | 1.33M | 1.93M | 2.52M |
| Cost of Revenue | 182.50K | 178.60K | 445.20K | 1.01M | 1.47M |
| Gross Profit | 632.90K | 1.05M | 881.70K | 911.90K | 1.06M |
| SG&A Expenses | 7.04M | 8.17M | 8.47M | 9.17M | 11.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.16M | 8.26M | 8.94M | 10.31M | 12.86M |
| Operating Income | -6.34M | -7.04M | -7.61M | -8.39M | -10.33M |
| Income Before Tax | -14.03M | -50.06M | -45.16M | -57.04M | -59.74M |
| Income Tax Expenses | 500.00 | -918.00K | -974.40K | -923.60K | -1.05M |
| Earnings from Continuing Operations | -14.03 | -49.14 | -44.18 | -56.12 | -58.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.03M | -49.14M | -44.18M | -56.12M | -58.69M |
| EBIT | -6.34M | -7.04M | -7.61M | -8.39M | -10.33M |
| EBITDA | -6.33M | -6.90M | -7.28M | -7.86M | -9.60M |
| EPS Basic | -477.22 | -657.96 | -345.47 | -- | -- |
| Normalized Basic EPS | 32.30 | -103.21 | -88.54 | -- | -- |
| EPS Diluted | -477.22 | -657.96 | -345.47 | -- | -- |
| Normalized Diluted EPS | 32.30 | -103.21 | -88.54 | -- | -- |
| Average Basic Shares Outstanding | 70.70K | 39.30K | 11.20K | -- | -- |
| Average Diluted Shares Outstanding | 70.70K | 39.30K | 11.20K | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |